These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35709702)

  • 21. Tumor-infiltrating mast cells stimulate ICOS
    Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
    J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
    Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
    World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
    Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of
    Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.
    Sakthivel P; Grunewald J; Eklund A; Bruder D; Wahlström J
    Clin Exp Immunol; 2016 Feb; 183(2):294-306. PubMed ID: 26415669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
    Cui G; Li Z; Ren J; Yuan A
    Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
    Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
    J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.
    O'Brien CA; Harris TH
    PLoS One; 2020; 15(1):e0228251. PubMed ID: 31978191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
    Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
    BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4
    Chauhan R; Awasthi V; Thakur RS; Pande V; Chattopadhyay D; Das J
    Malar J; 2022 Feb; 21(1):32. PubMed ID: 35109868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.
    Chen L; Ma H; Hu H; Gao L; Wang X; Ma J; Gao Q; Liu B; Zhou G; Liang C
    BMC Cancer; 2014 Jul; 14():489. PubMed ID: 25000974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.
    Cai XY; Ni XC; Yi Y; He HW; Wang JX; Fu YP; Sun J; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Medicine (Baltimore); 2016 Oct; 95(40):e4989. PubMed ID: 27749555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.
    Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S
    Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.
    Sainson RCA; Thotakura AK; Kosmac M; Borhis G; Parveen N; Kimber R; Carvalho J; Henderson SJ; Pryke KL; Okell T; O'Leary S; Ball S; Van Krinks C; Gamand L; Taggart E; Pring EJ; Ali H; Craig H; Wong VWY; Liang Q; Rowlands RJ; Lecointre M; Campbell J; Kirby I; Melvin D; Germaschewski V; Oelmann E; Quaratino S; McCourt M
    Cancer Immunol Res; 2020 Dec; 8(12):1568-1582. PubMed ID: 32999002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.
    Fu J; Zhang Z; Zhou L; Qi Z; Xing S; Lv J; Shi J; Fu B; Liu Z; Zhang JY; Jin L; Zhao Y; Lau GK; Zhao J; Wang FS
    Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.